Indecainide
Indecainide (INN, trade name Decabid) is a class Ic antiarrhythmic agent.[1] Developed and marketed by Lilly, it has now been discontinued.
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H24N2O |
Molar mass | 308.425 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
References
- Jaillon P, Drici M (December 1989). "Recent antiarrhythmic drugs". The American Journal of Cardiology. 64 (20): 65J–69J. doi:10.1016/0002-9149(89)91203-4. PMID 2688391.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.